Class | Comment |
Metformin | Not recommended in severe/critical patients; patients with gastrointestinal symptoms or lack of oxygen. |
Secretagogue | Mild/moderate patients using glucocorticoid: · Short-acting agents can be used in early stage; · Middle/long-acting agents if FPG and/or PPG increased or in advanced stage. |
α-glucosidase inhibitor | Can be used to control PPG. Not recommended in severe/critical patients; or in patients with gastrointestinal symptoms. |
TZD | Can be used during the process of glucocorticoid treatment. Regime should be adjusted according to treatment effect. |
DPP-4i | Not recommended |
SGLT-2i | Not recommended for COVID-19 patients having stress reaction at different levels. |